A scrutiny of the biochemical pathways from Ang II to Ang-(3-4) in renal basolateral membranes

Regulatory Peptides

Volumn 158, Issue 1-3, 2009, Pages 47-56

  Axelband, Flavia ^a,b   Dias, Juliana ^a,b   Miranda, Filipe ^a,b   Ferrão, Fernanda M ^a,b   Barros, Nilana M ^c   Carmona, Adriana K ^c   Lara, Lucienne S ^a,b   Vieyra, Adalberto ^a,b  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b Instituto Nacional de Ciencia e Tecnologia em Biologia Estrutural e Bioimagem   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Ang (3 4); Angiotensin metabolism; Basolateral membranes; Kidney cells; Peptidases; Plasma membrane Ca2+ ATPase

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); AMINOPEPTIDASE; ANGIOTENSIN; ANGIOTENSIN II; ANGIOTENSIN[1-4]; ANGIOTENSIN[1-5]; ANGIOTENSIN[1-7]; ANGIOTENSIN[3-4]; ARGININE CARBOXYPEPTIDASE; BESTATIN; DIPEPTIDYL CARBOXYPEPTIDASE; MEMBRANE METALLOENDOPEPTIDASE; PROLINE CARBOXYPEPTIDASE; THIORPHAN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BASOLATERAL MEMBRANE; BIOCHEMISTRY; CATALYSIS; CONTROLLED STUDY; ENZYME ACTIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; KIDNEY PROXIMAL TUBULE; METABOLISM; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION;

ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BASEMENT MEMBRANE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HYDROLYSIS; KIDNEY; LEUCINE; LYSINE CARBOXYPEPTIDASE; PEPTIDYL-DIPEPTIDASE A; THIORPHAN;

EID: 70349743680     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2009.08.004     Document Type: Article

References (43)

1. Axelband F., Assunção-Miranda I., de Paula I.R., Ferrão F.M., Dias J., Miranda A., Miranda F., Lara L.S., and Vieyra A. Ang-(3-4) suppresses inhibition of renal plasma membrane calcium pump by Ang II. Regul Pept 155 (2009) 81-90
2. Handa R.K. Metabolism alters the selectivity of angiotensin-(1-7) receptor ligands for angiotensin receptors. J Am Soc Nephrol 11 (2000) 1377-1386
3. Santos R.A., Campagnole-Santos M.J., and Andrade S.P. Angiotensin-(1-7): an update. Regul Pept 91 (2000) 45-62
4. Siragy H.M., Howell N.L., Ragsdale N.V., and Carey R.M. Renal interstitial fluid angiotensin: modulation by anesthesia, epinephrine, sodium depletion, and renin inhibition. Hypertension 25 (1995) 1021-1024
5. Siragy H.M., and Carey R.M. Protective role of the angiotensin AT2 receptor in a renal wrap hypertension model. Hypertension 33 (1999) 1237-1242
6. Nishiyama A., Seth D.M., and Navar L.G. Renal interstitial fluid concentrations of angiotensins I and II in anesthetized rats. Hypertension 39 (2002) 129-134
7. Nishiyama A., Seth D.M., and Navar L.G. Renal interstitial fluid angiotensin I and angiotensin II concentrations during local angiotensin-converting enzyme inhibition. J Am Soc Nephrol 13 (2002) 2207-2212
8. Saito Y., Wanezaki K., Kawato A., and Imayasu S. Structure and activity of angiotensin I converting enzyme inhibitory peptides from sake and sake lees. Biosci Biotechnol Biochem 58 (1994) 1767-1771
9. Matsufuji H., Matsui T., Ohshige S., Kawasaky T., Osajima K., and Osajima Y. Antihypertensive effects of angiotensin fragments in SHR. Biosci Biotechnol Biochem 59 (1995) 1398-1401
10. Pentzien A.K., and Meisel H. Transepithelial transport and stability in blood serum of angiotensin-I-converting enzyme inhibitory dipeptides. Z Naturforsch. [C] 63 (2008) 451-459
11. 2+)-ATPase from rabbit kidney proximal tubules. J Biol Chem 266 (1991) 10249-10253
12. Harris P.J., Hiranyachattada S., Antoine A.M., Walker L., Reilly A.M., and Eitle E. Regulation of renal tubular sodium transport by angiotensin II and atrial natriuretic factor. Clin Exp Pharmacol Physiol Suppl 3 (1996) S112-S118
13. Allred A.J., Diz D.I., Ferrario C.M., and Chappell M.C. Pathways for angiotensin-(1-7) metabolism in pulmonary and renal tissues. Am J Physiol Renal Physiol 279 (2000) F841-F850
14. Shaltout H.A., Westwood B.M., Averill D.B., Ferrario C.M., Figueroa J.P., Diz D.I., Rose J.C., and Chappell M.C. Angiotensin metabolism in renal proximal tubules, urine, and serum of sheep: evidence for ACE2-dependent processing of angiotensin II. Am J Physiol Renal Physiol 292 (2007) F82-F91
15. Brosnihan K.B., Santos R.A.S., Block C.H., Schiavone M.T., Welches W.R., Chappell M.C., Khosla M.C., Greene L.J., and Ferrario C.M. Biotransformations of angiotensins in the central nervous system. Ther Res 9 (1988) 48-59
16. Vickers C., Hales P., Kaushik V., Dick L., Gavin J., Tang J., Godbout K., Parsons T., Baronas E., Hsieh F., Acton S., Patane M., Nichols A., and Tummino P. Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. J Biol Chem 277 (2002) 14838-14843
17. Ferrario C.M., and Chappell M.C. Novel angiotensin peptides. Cell Mol Life Sci 61 (2004) 2720-2727
18. Araujo M.C., Melo R.L., Cesari M.H., Juliano M.A., Juliano L., and Carmona A.K. Peptidase specificity characterization of C- and N-terminal catalytic sites of angiotensin I-converting enzyme. Biochemistry 39 (2000) 8519-8525
19. Alves L.C., Almeida P.C., Franzoni L., Juliano L., and Juliano M.A. Synthesis of N alpha-protected aminoacyl 7-amino-4-methyl-coumarin amide by phosphorus oxychloride and preparation of specific fluorogenic substrates for papain. Pept Res 9 (1996) 92-96
20. Barros N.M., Campos M., Bersanetti P.A., Oliveira V., Juliano M.A., Boileau G., Juliano L., and Carmona A.K. Neprilysin carboxydipeptidase specificity studies and improvement in its detection with fluorescence energy transfer peptides. Biol Chem 388 (2007) 447-455
21. Vieyra A., Nachbin L., de Dios-Abad E., Goldfeld M., Meyer-Fernandes J.R., and de Moraes L. Comparison between calcium transport and adenosine triphosphatase activity in membrane vesicles derived from rabbit kidney proximal tubules. J Biol Chem 261 (1986) 4247-4255
22. 2+)ATPase through a pathways sensitive to cholera toxin and sphingosine. Eur J Biochem 264 (1999) 3274-3285
23. + transport and membrane potential in inside-out renal basolateral vesicles. Biochim Biophys Acta 728 (1983) 39-49
24. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 193 (1951) 265-275
25. Grubmeyer C., and Penefsky H.S. The presence of two hydrolytic sites on beef heart mitochondrial adenosine triphosphatase. J Biol Chem 256 (1986) 3718-3727
26. Sorenson M.M., Coelho H.S., and Reuben J.P. Caffeine inhibition of calcium accumulation by the sarcoplasmic reticulum in mammalian skinned fibers. J Membr Biol 90 (1986) 219-230
27. Plummer Jr. T.H., and Ryan T.J. A potent mercapto bi-product analogue inhibitor for human carboxypeptidase N. Biochem Biophys Res Commun 98 (1981) 448-454
28. Karamyan V.T., and Speth R.C. Enzymatic pathways of the brain renin-angiotensin system: unsolved problems and continuing challenges. Regul Pept 143 (2007) 15-27
29. 2-receptor antagonists. Regul Pept 127 (2005) 151-157
30. Matsui T., Tamaya K., Seki E., Osajima K., Matsumoto K., and Kawasaki T. Val-Tyr as a natural antihypertensive dipeptide can be absorbed into the human circulatory blood system. Clin Exp Pharmacol Physiol 29 (2002) 204-208
31. Matsui T., Hayashi A., Tamaya K., Matsumoto K., Kawasaki T., Murakami K., and Kimoto K. Depressor effect induced by dipeptide, Val-Tyr, in hypertensive transgenic mice is due, in part, to the suppression of human circulating renin-angiotensin system. Clin Exp Pharmacol Physiol 30 (2003) 262-265
32. Matsui T., Imamura M., Oka H., Osajima K., Kimoto K., Kawasaki T., and Matsumoto K. Tissue distribution of antihypertensive dipeptide, Val-Tyr, after its single oral administration to spontaneously hypertensive rats. J Pept Sci 10 (2004) 535-545
33. 2+ channel inhibition in cultured vascular smooth muscle cells. Hypertens Res 28 (2005) 545-552
34. Tanaka M., Matsui T., Ushida Y., and Matsumoto K. Vasodilating effect of di-peptides in thoracic aorta from spontaneously hypertensive rats. Biosci Biotechnol Biochem 70 (2006) 2292-2295
35. Tanaka M., Tokuyasu M., Matsui T., and Matsumoto K. Endothelium-independent vasodilation effect of di- and tri-peptides in thoracic aorta of Sprague-Dawley rats. Life Sci 82 (2008) 869-875
36. Mallela J., Perkins R., Yang J., Pedigo S., Rimoldi J.M., and Shariat-Madar Z. The functional importance of the N-terminal region of human prolylcarboxypeptidase. Biochem Biophys Res Commun 374 (2008) 635-640
37. Rice G.I., Thomas D.A., Grant P.J., Turner A.J., and Hooper N.M. Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism. Biochem J 383 (2004) 45-51
38. Oudit G.Y., Herzenberg A.M., Kassiri Z., Wong D., Reich H., Khokha R., Crackower M.A., Backx P.H., Penninger J.M., and Scholey J.W. Loss of angiotensin-converting enzyme-2 leads to the late development of angiotensin II dependent glomerulosclerosis. Am J Pathol 168 (2006) 1808-1820
39. Danziger R.S. Aminopeptidase N in arterial hypertension. Heart Fail Rev 13 (2008) 293-298
40. Yamada K., Iyer S.N., Chappell M.C., Ganten D., and Ferrario C.M. Converting enzyme determines plasma clearance of angiotensin-(1-7). Hypertension 32 (1998) 496-502
41. Abramić M., Zubanović M., and Vitale L. Dipeptidyl peptidase III from human erythrocytes. Biol Chem Hoppe-Seyler 369 (1988) 29-38
42. Alba F., Arenas J.C., and Lopez M.A. Properties of rat brain dipeptidyl aminopeptidases in the presence of detergents. Peptides 16 (1995) 325-329
43. Li L., Wu Q., Wang J., Bucy R.P., and Cooper M.D. Widespread tissue distribution of aminopeptidase A, an evolutionarily conserved ectoenzyme recognized by the BP-1 antibody. Tissue Antigens 42 (1993) 488-496